2002 CFR Title 10, Volume 1

Title 10--Energy CHAPTER I--NUCLEAR REGULATORY COMMISSION PART 35--MEDICAL USE OF BYPRODUCT MATERIAL
	35.1	Purpose and scope.
	35.2	Definitions.
	35.5	Maintenance of records.
	35.6	Provisions for research involving human subjects.
	35.7	FDA, other Federal, and State requirements.
	35.8	Information collection requirements: OMB approval.
	35.11	License required.
	35.12	Application for license, amendment, or renewal.
	35.13	License amendments.
	35.14	Notifications.
	35.15	Exemptions regarding Type A specific licenses of broad scope.
	35.18	License issuance.
	35.19	Specific exemptions.
	35.20	ALARA program.
	35.21	Radiation Safety Officer.
	35.22	Radiation Safety Committee.
	35.23	Statements of authority and responsibilities.
	35.25	Supervision.
	35.29	Administrative requirements that apply to the provision of mobile nuclear medicine service.
	35.31	Radiation safety program changes.
	35.32	Quality management program.
	35.33	Notifications, reports, and records of misadministrations.
	35.49	Suppliers for sealed sources or devices for medical use.
	35.50	Possession, use, calibration, and check of dose calibrators.
	35.51	Calibration and check of survey instruments.
	35.52	Possession, use, calibration, and check of instruments to measure dosages of alpha- or beta-emitting radionuclides.
	35.53	Measurement of dosages of unsealed byproduct material for medical use.
	35.57	Authorization for calibration and reference sources.
	35.59	Requirements for possession of sealed sources and brachytherapy sources.
	35.60	Syringe shields and labels.
	35.61	Vial shields and labels.
	35.70	Surveys for contamination and ambient radiation exposure rate.
	35.75	Release of individuals containing radiopharmaceuticals or permanent implants.
	35.80	Technical requirements that apply to the provision of mobile nuclear medicine service.
	35.90	Storage of volatiles and gases.
	35.92	Decay-in-storage.
	35.100	Use of unsealed byproduct material for uptake, dilution, and excretion studies.
	35.120	Possession of survey instrument.
	35.200	Use of unsealed byproduct material for imaging and localization studies.
	35.204	Permissible molybdenum-99 concentration.
	35.205	Control of aerosols and gases.
	35.220	Possession of survey instruments.
	35.300	Use of unsealed byproduct material for therapeutic administration.
	35.310	Safety instruction.
	35.315	Safety precautions.
	35.320	Possession of survey instruments.
	35.400	Use of sources for brachytherapy.
	35.404	Release of patients or human research subjects treated with temporary implants.
	35.406	Brachytherapy sources inventory.
	35.410	Safety instruction.
	35.415	Safety precautions.
	35.420	Possession of survey instrument.
	35.500	Use of sealed sources for diagnosis.
	35.520	Availability of survey instrument.
	35.600	Use of a sealed source in a teletherapy unit.
	35.605	Maintenance and repair restrictions.
	35.606	License amendments.
	35.610	Safety instruction.
	35.615	Safety precautions.
	35.620	Possession of survey instrument.
	35.630	Dosimetry equipment.
	35.632	Full calibration measurements.
	35.634	Periodic spot-checks.
	35.636	Safety checks for teletherapy facilities.
	35.641	Radiation surveys for teletherapy facilities.
	35.643	Modification of teletherapy unit or room before beginning a treatment program.
	35.645	Reports of teletherapy surveys, checks, tests, and measurements.
	35.647	Five-year inspection.
	35.900	Radiation Safety Officer.
	35.901	Training for experienced Radiation Safety Officer.
	35.910	Training for uptake, dilution, and excretion studies.
	35.920	Traininq for imaging and localization studies.
	35.930	Training for therapeutic use of unsealed byproduct material.
	35.932	Training for treatment of hyperthyroidism.
	35.934	Training for treatment of thyroid carcinoma.
	35.940	Training for use of brachytherapy sources.
	35.941	Training for ophthalmic use of strontium-90.
	35.950	Training for use of sealed sources for diagnosis.
	35.960	Training for teletherapy.
	35.961	Training for teletherapy physicist.
	35.970	Training for experienced authorized users.
	35.971	Physician training in a three month program.
	35.972	Recentness of training.
	35.980	Training for an authorized nuclear pharmacist.
	35.981	Training for experienced nuclear pharmacists.
	35.990	Violations.
	35.991	Criminal penalties.
	35.999	Resolution of conflicting requirements during transition period.